Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, South Korea; email:
Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, South Korea.
Annu Rev Pathol. 2016 May 23;11:283-312. doi: 10.1146/annurev-pathol-012615-044446. Epub 2016 Feb 22.
During tumor evolution, cancer cells can accumulate numerous genetic alterations, ranging from single nucleotide mutations to whole-chromosomal changes. Although a great deal of progress has been made in the past decades in characterizing genomic alterations, recent cancer genome sequencing studies have provided a wealth of information on the detailed molecular profiles of such alterations in various types of cancers. Here, we review our current understanding of the mechanisms and consequences of cancer genome instability, focusing on the findings uncovered through analysis of exome and whole-genome sequencing data. These analyses have shown that most cancers have evidence of genome instability, and the degree of instability is variable within and between cancer types. Importantly, we describe some recent evidence supporting the idea that chromosomal instability could be a major driving force in tumorigenesis and cancer evolution, actively shaping the genomes of cancer cells to maximize their survival advantage.
在肿瘤进化过程中,癌细胞可以积累大量的遗传改变,从单个核苷酸突变到整个染色体变化都有。尽管在过去几十年中,在描述基因组改变方面已经取得了很大进展,但最近的癌症基因组测序研究提供了大量关于各种类型癌症中这些改变的详细分子谱的信息。在这里,我们回顾了我们对癌症基因组不稳定性的机制和后果的现有理解,重点是通过外显子组和全基因组测序数据分析揭示的发现。这些分析表明,大多数癌症都有基因组不稳定性的证据,而且在癌症类型内和类型之间,不稳定性的程度是可变的。重要的是,我们描述了一些最近的证据,支持染色体不稳定性可能是肿瘤发生和癌症进化的主要驱动力的观点,积极塑造癌细胞的基因组,以最大限度地提高它们的生存优势。